Research

Found 15 results

Sort by: Author Title [ Year (Desc)]
Filters: Author is CJ McDougle  [Clear All Filters]
2009
Stigler KA, Diener JT, Kohn AE, Li L, Erickson CA, Posey DJ, McDougle CJ.  2009.  Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger’s Disorder: A 14-Week, Prospective, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 19(3):265-274. Abstract
Handen BL, Melmed RD, Hansen RL, Aman MG, Burnham DL, Bruss JB, McDougle CJ.  2009.  A Double-Blind, Placebo-Controlled Trial of Oral Human Immunoglobulin for Gastrointestinal Dysfunction in Children with Autistic Disorder. Journal of Autism and Developmental Disorders. 39(5):796-805.
2008
McDougle CJ, Stigler KA, Erickson CA, Posey DJ.  2008.  Atypical Antipsychotics in Children and Adolescents with Autistic and Other Pervasive Developmental Disorders. J Clin Psychiatry. 69(Suppl 4):15-20.
Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A et al..  2008.  Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior. Journal of Child and Adolescent Psychopharmacology. 18(3):227-236.
Posey DJ, Erickson CA, McDougle CJ.  2008.  Developing Drugs for Core Social and Communication Impairment in Autism. Child Adolesc Psychiatric Clin N Am. 17(4):787-801.
2007
Posey DJ, Stigler KA, Erickson CA, McDougle CJ.  2007.  Antipsychotics in the Treatment of Autism. The Journal of Clinical Investigation. 118(1):6-14.
Johnson CR, Handen BL, Butter E, Wagner A, Mulick J, Sukhodolsky DG, Williams S, Swiezy NA, Arondol LE, Aman MG et al..  2007.  Development of Parent Training Program for Children with Pervasive Developmental Disorders. Behavioral Interventions. 22(3):201-221.
Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ et al..  2007.  Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism. Biol Psychiatry. 61(4):545-550.
Posey DJ, McDougle CJ.  2007.  Guanfacine and Guanfacine Extended Release: Treatment for ADHD and Related Disorders. CNS Drug Reviews. 13(4):465-474.
Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ.  2007.  A Retrospective Study of Memantine in Children and Adolescents with Pervasive Developmental Disorders. Psychopharmacology. 191:141-147.
2006
Lindsay RL, Arnold LE, Arnold MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E et al..  2006.  Dietary Status and Impact of Risperidone on Nutritional Balance in Children with Autism: A Pilot Study. Journal of Intellectual & Developmental Disability. 31(4):204-209.
Posey DJ, Weigand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJ.  2006.  Open-Label Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5):599-610.
McDougle CJ, Stigler KA, Erickson CA, Posey DJ.  2006.  Pharmacology of Autism. Clinical Neuroscience Research. 6:179-188.
Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B et al..  2006.  A Prospective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5):589-598.
Stigler KA, Posey DJ, McDougle CJ.  2006.  Ramelteon for Insomnia in Two Youths with Autistic Disorder. Journal of Child and Adolescent Psychopharmacology. 16(5):631-636.
|